Effects of SGLT2 inhibitors on the metabolic environment and uraemic toxins

Nat Rev Nephrol. 2024 Mar;20(3):155. doi: 10.1038/s41581-024-00814-4.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Uremia* / metabolism
  • Uremic Toxins

Substances

  • Uremic Toxins
  • Sodium-Glucose Transporter 2 Inhibitors